In uveal melanoma, mutation of the BAP1 gene is associated with loss of nBAP1 expression, which has been proposed as a surrogate clinical marker (Kalirai et al., 2014, Koopmans et al., 2014). Here, BAP1 is linked to uveal melanoma.